Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
Peter R. Galle, Andrew X. Zhu(Massachusetts General Hospital), Masatoshi Kudo(Kindai University), Shukui Qin(Sichuan University), Stephen L. Chan(Chinese University of Hong Kong), Sudhakar Chintharlapalli(Texas A&M Health Science Center), Josep M. Llovet(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Paolo Abada(University of California, San Diego), William R. Schelman, Morris Sherman(Nihon University), Friedrich Foerster(Johannes Gutenberg University Mainz)
Cited by 591
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k